Paradigm Health to Acquire Flatiron Health’s Clinical Research Business, Pioneering a New Era in Oncology Trials
December 29, 2025 – A significant shift is underway in the landscape of clinical research, particularly within oncology. Paradigm Health will acquire Flatiron Health’s Clinical Research Business, forging a strategic partnership designed to revitalize how clinical trials are conducted and expand patient access. This acquisition promises to reshape the clinical research ecosystem, benefiting providers, sponsors, and, most importantly, patients.
A Powerful Combination for Enhanced Research
The transaction encompasses Flatiron’s extensive, tech-enabled U.S. oncology research network. It also includes Flatiron’s thorough suite of clinical research solutions. Together, Paradigm Health and Flatiron Health aim to overcome longstanding challenges in clinical trial execution. They are focused on accelerating the delivery of innovative therapies to those who need them most.
What This Means for You
This collaboration represents a commitment to:
* Broadening Patient Access: More patients will have the possibility to participate in potentially life-saving clinical trials.
* Streamlining Trial Processes: Expect faster, more efficient clinical trials through integrated technology and expertise.
* Improving Data Quality: Enhanced data collection and analysis will lead to more reliable research outcomes.
* Empowering Providers & Sponsors: Both providers and sponsors will gain access to powerful tools and resources to optimize their research efforts.
Rebuilding the Clinical Research Ecosystem
Paradigm Health and Flatiron Health recognize the need for a more connected and efficient clinical research process. They are dedicated to rebuilding the ecosystem from the ground up. This includes addressing barriers to participation, improving data sharing, and fostering collaboration among all stakeholders.
This isn’t just about conducting trials faster; it’s about conducting them better. You can anticipate a future where clinical research is more inclusive, more effective, and ultimately, more impactful for patients facing cancer.
Looking Ahead
The partnership between Paradigm Health and Flatiron Health signals a new chapter in clinical research. It’s a testament to the power of collaboration and innovation. This acquisition is poised to drive meaningful advancements in oncology and beyond, offering hope for improved outcomes and a brighter future for patients worldwide.